Susceptibility of Mycobacteria to Rifampin

The Mycobacterium species M. tuberculosis, M. avium-intracellulare, M. kansasii, M. marinum, M. scrofulaceum, M. fortuitum, M. terrae, and M. gordonae were analyzed for their susceptibility to rifampin. M. tuberculosis, M. kansasii, and M. marinum were susceptible to the antibiotic, and resistant populations developed as a result of the interplay of mutation and selection. The mutation rates (susceptibility → resistance) were calculated to be 4.9 × 10−10 and 1.7 × 10−9 mutations per bacterium per generation in, respectively, M. kansasii and M. marinum. M. fortuitum was found to be naturally resistant to the antibiotic, whereas the nature of resistance in the other species was unclear and is discussed.

[1]  D. Mitchison,et al.  The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis. , 1972, The American review of respiratory disease.

[2]  G. Lancini,et al.  Mechanism of Action of Rifampin on Mycobacterium smegmatis , 1971, Journal of bacteriology.

[3]  E. Wolinsky,et al.  Rifampin: in vitro effect on atypical mycobacteria. , 1971, The American review of respiratory disease.

[4]  B. Weisblum,et al.  Erythromycin-Inducible Resistance in Staphylococcus aureus: Requirements for Induction , 1971, Journal of bacteriology.

[5]  H. David,et al.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. , 1970, Applied microbiology.

[6]  G. Hobby,et al.  Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969. , 1970, The American review of respiratory disease.

[7]  W. Lester,et al.  In vitro susceptibility of mycobacteria to rifampin. , 1969, The American review of respiratory disease.

[8]  R. Novick.  Extrachromosomal inheritance in bacteria. , 1969, Bacteriological reviews.

[9]  C. Woodley,et al.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions. , 1969, Applied microbiology.

[10]  G. Hobby,et al.  In vitro activity of rifampin against the H37RV strain of Mycobacterium tuberculosis. , 1969, The American review of respiratory disease.

[11]  L. Verbist,et al.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood. , 1968, The American review of respiratory disease.

[12]  W. Wehrli,et al.  Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria. , 1968, Biochemical and biophysical research communications.

[13]  K. Honikel,et al.  The specific inhibition of the DNA-directed RNA synthesis by rifamycin. , 1967, Biochimica et biophysica acta.

[14]  A. Wallace,et al.  The susceptibility of mycobacteria to rifamide and rifampicin. , 1967, Tubercle.

[15]  P. Pattee,et al.  INDUCIBLE RESISTANCE TO ERYTHROMYCIN IN STAPHYLOCOCCUS AUREUS , 1964, Journal of bacteriology.

[16]  W. Gundersen.  NEW TYPE OF STREPTOMYCIN RESISTANCE RESULTING FROM ACTION OF THE EPISOMELIKE MUTATOR FACTOR IN ESCHERICHIA COLI , 1963, Journal of bacteriology.

[17]  P HAUDUROY,et al.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. , 1963, Bulletin of the World Health Organization.

[18]  V. Bryson,et al.  SELECTION OF RESISTANT STRAINS OF ESCHERICHIA COLI BY ANTIBIOTICS AND ANTIBACTERIAL AGENTS: ROLE OF NORMAL AND MUTATOR STRAINS. , 1963, Antimicrobial agents and chemotherapy.

[19]  H. P. Treffers,et al.  A Factor (or Mutator Gene) Influencing Mutation Rates in Escherichia Coli. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Atwood,et al.  Selective mechanisms in bacteria. , 1951, Cold Spring Harbor symposia on quantitative biology.